Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 825, pseudogene (RN7SL825P)

Target
RN7SL825P
Molecular classification
Pseudogene, Non-coding RNA family member
01

Overview

RN7SL825P (RNA, 7SL, cytoplasmic 825, pseudogene) is a genomic locus annotated in humans as a processed pseudogene derived from the 7SL RNA family[6][4][3]. The parent molecule, 7SL RNA, is an integral non-coding RNA within the signal recognition particle (SRP), playing an essential role in protein targeting to membranes via co-translational mechanisms[1][5]. However, RN7SL825P itself is a truncated, non-functional copy of 7SL RNA, produced from reverse transcription and erroneous integration into the genome[3]. Like other processed pseudogenes, it lacks regulatory elements and is not expressed as a functional gene product[2][3]. While pseudogenes occasionally participate in regulatory RNA networks, there is no evidence for RN7SL825P functioning as a biomarker, disease gene, or therapeutic target, nor for any clinical or pharmaceutical relevance at this time[6][7][4]. If structured information is needed for database curation, these entries should indicate its status as a pseudogene, and not as a classical receptor, enzyme, transporter, or therapeutic target.

Other names
RNA, 7SL, cytoplasmic 825, pseudogeneRN7SL825P
02

Mechanism of action

Not applicable; no drugs are described to target RN7SL825P

03

Biological functions

None directly established for RN7SL825P; pseudogenes may sometimes regulate gene expression post-transcriptionally or act as competing endogenous RNAs in some contexts, but such specific functions are not attributed to RN7SL825P in the available literatureGeneral pseudogene functions (not specific to RN7SL825P) can include antisense regulation and modulation of parental gene transcription via various RNA-mediated mechanisms
04

Disease associations

None directly documented for RN7SL825POther 7SL pseudogenes in the same family are involved in retrotransposon activity and may be related to disease processes through regulatory functions, but RN7SL825P itself is not clearly implicated in any specific disease based on current dataAs a pseudogene, its disease relevance is primarily theoretical unless further studies indicate a regulatory or biomarker role.
05

Safety considerations

None known; pseudogenes generally pose no safety concerns as therapeutic targets due to their lack of protein-coding
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 825, pseudogene (RN7SL825P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 825, pseudogene (RN7SL825P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call